Ironwood Pharmaceuticals is an entrepreneurial pharmaceutical company dedicated to the art and science of great drugmaking. LINZESS (linaclotide), Ironwood’s guanylate cyclase-C agonist, is an FDA-approved drug for the treatment of adults with irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation. Ironwood also has a growing pipeline of additional drug candidates in earlier stages of development.

Contact Info

301 Binney Street, 2nd Floor, Cambridge, MA, 02142
Tel: ( 617) 621-7722

Polaris Lead

Terry McGuire

Follow on TwitterVisit our Twitter page
Social Media